137 related articles for article (PubMed ID: 33848528)
21. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
22. PLA-coated Imwitor
Abbas H; El-Deeb NM; Zewail M
Pharm Dev Technol; 2021 Jul; 26(6):682-692. PubMed ID: 33952085
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of pro-inflammatory markers IL-6 and TNF-α in rheumatoid arthritis using nano-lipidic carriers of a quinone-based phenolic: an in vitro and in vivo study.
Pal RR; Rajpal V; Singh N; Singh S; Mishra N; Singh P; Maurya P; Alka ; Saraf SA
Drug Deliv Transl Res; 2023 Feb; 13(2):627-641. PubMed ID: 35963927
[TBL] [Abstract][Full Text] [Related]
24. Intra-articular leflunomide-loaded poly(ε-caprolactone) implants to treat synovitis in rheumatoid arthritis.
Gomes TF; Gualberto FCM; Perasoli FB; Andrade FP; Moura SAL; Da Silva GR
Pharmazie; 2019 Apr; 74(4):212-220. PubMed ID: 30940304
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate Aspasomes Against Rheumatoid Arthritis: Optimized Hydrogel Loaded Liposomal Formulation with In Vivo Evaluation in Wistar Rats.
Ghosh S; Mukherjee B; Chaudhuri S; Roy T; Mukherjee A; Sengupta S
AAPS PharmSciTech; 2018 Apr; 19(3):1320-1336. PubMed ID: 29340978
[TBL] [Abstract][Full Text] [Related]
26. Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy.
Li S; Chen L; Wang G; Xu L; Hou S; Chen Z; Xu X; Wang X; Liu F; Du YZ
J Nanobiotechnology; 2018 Dec; 16(1):105. PubMed ID: 30594254
[TBL] [Abstract][Full Text] [Related]
27. Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: a retrospective study.
Deng D; Zhou J; Li M; Li S; Tian L; Zou J; Wang T; Wu J; Zeng F; Yang J
Sci Rep; 2020 Jul; 10(1):12339. PubMed ID: 32704073
[TBL] [Abstract][Full Text] [Related]
28. Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients.
Katayama K; Matsuno T
Mod Rheumatol; 2009; 19(5):513-21. PubMed ID: 19603251
[TBL] [Abstract][Full Text] [Related]
29. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
[TBL] [Abstract][Full Text] [Related]
30. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
Kim G; Barner JC; Rascati K; Richards K
Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
[TBL] [Abstract][Full Text] [Related]
31. [Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].
Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
Z Rheumatol; 2004 Feb; 63(1):59-75. PubMed ID: 14991279
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
33. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
Flendrie M; Creemers MC; Welsing PM; van Riel PL
Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
[TBL] [Abstract][Full Text] [Related]
34. Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis.
Kumar V; Leekha A; Tyagi A; Kaul A; Mishra AK; Verma AK
Pharm Res; 2017 Mar; 34(3):654-667. PubMed ID: 28097508
[TBL] [Abstract][Full Text] [Related]
35. The role of Chinese herbal medicine in the management of adverse drug reactions of leflunomide in treating rheumatoid arthritis.
Wang W; Zhou H; Liu L
Phytomedicine; 2020 Mar; 68():153136. PubMed ID: 32062477
[TBL] [Abstract][Full Text] [Related]
36. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S
Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.
Finckh A; Dehler S; Gabay C;
Ann Rheum Dis; 2009 Jan; 68(1):33-9. PubMed ID: 18230627
[TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Maetzel A; Strand V; Tugwell P; Wells G; Bombardier C
Arthritis Rheum; 2002 Dec; 47(6):655-61. PubMed ID: 12522841
[TBL] [Abstract][Full Text] [Related]
39. Anti-arthritic effect of β-caryophyllene and its ameliorative role on methotrexate and/or leflunomide-induced side effects in arthritic rats.
El-Sheikh SMA; Abd El-Alim AEF; Galal AAA; El-Sayed RG; El-Naseery NI
Life Sci; 2019 Sep; 233():116750. PubMed ID: 31408659
[TBL] [Abstract][Full Text] [Related]
40. Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis.
Karanikolas G; Charalambopoulos D; Andrianakos A; Antoniades C; Katsilambros N
J Rheumatol; 2006 Mar; 33(3):486-9. PubMed ID: 16511917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
